Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05956184
Other study ID # ACH-KHD-MIH-01
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date July 13, 2023
Est. completion date September 1, 2023

Study information

Verified date September 2023
Source Ankara City Hospital Bilkent
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of this study is to compare the pain score between the direct method and the conventional method in patients who have undergone copper or hormonal intrauterine devices (IUD) for contraception and to find an answer to the question of which method is better.


Description:

The intrauterine device (IUD) is one of the commonly used methods of contraception due to its effectiveness in providing reliable contraception, its ease of application, non-obstruction of sexual life, affordability, minimal absolute contraindications, and reversibility. Despite this increasing preference, concerns regarding the use of both levonorgestrel-releasing and copper IUDs due to the potential pain and fear of pain during insertion, which has hindered the adoption of this method. Although the conventional method is used for intrauterine device insertion, the authors defined the direct method, also known as the torpedo technique, in 2006. IUD practitioners have started to prefer this direct method because it is simpler, faster and has fewer insertion steps than the conventional technique. However, IUD practitioners should apply the most painless and tolerable method to women who choose an IUD for contraception. Therefore, in order to understand which method is less painful, patients will be divided into 2 groups as those who have IUD inserted with the conventional method and those who have IUD inserted with the direct method. At the end of the procedure, participants in both groups will be asked to rate the most severe pain they experienced during the procedure according to the Visual Analogue Scale (VAS) (from 0 to 10). In the conventional method: the anterior lip of the cervix was grasped and pulled with Pozzi forceps, and after entering the uterine cavity with a hysterometry the IUD was inserted. In the direct method: the anterior lip of the cervix was grasped and pulled with Pozzi forceps, and without using hysterometry the IUD was directly inserted.


Recruitment information / eligibility

Status Completed
Enrollment 128
Est. completion date September 1, 2023
Est. primary completion date September 1, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 45 Years
Eligibility Inclusion Criteria: - Volunteer to participate in the study - Preferring an intrauterine device for the contraceptive method Exclusion Criteria: - Patients with uterine leiomyoma - Patients with endometriosis - Patients with chronic pelvic pain - Patients with familial mediterranean fever - Patients who experienced complications during the procedure - Patients who developed vasovagal reactions - Patients who had previously used an IUD for any reason - Patients with uterine anomalies

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Intrauterine Device Insertion
All womens will be placed in a gynecological position and underwent a bimanual examination to better determine whether the uterus was in the anteverted or retroverted position. Subsequently, a speculum will be inserted, and the cervix will be disinfected with betadine. In the conventional method: the anterior lip of the cervix is grasped and pulled with Pozzi forceps, and after entering the uterine cavity with a hysterometry the IUD is inserted. In the direct method: the anterior lip of the cervix is grasped and pulled with Pozzi forceps, and without using hysterometry the IUD is directly inserted. The strings will be cut approximately 2-3 cm after the cervix, and the Pozzi forceps and speculum will be removed. The accuracy of the IUD placement will be confirmed using pelvic ultrasound. The process will take about five minutes.

Locations

Country Name City State
Turkey Ankara City Hospital Ankara Çankaya

Sponsors (1)

Lead Sponsor Collaborator
Ankara City Hospital Bilkent

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary Visual Analogue Scale (VAS) This is a numeric pain score evaluated as "painless" (score=0) and "worst pain" (score=10). Score <3 mild pain, 3-6 mild-moderate pain, and >6 moderate-to-severe pain. Thirty minutes
See also
  Status Clinical Trial Phase
Completed NCT04782583 - Shifting of Intrauterine Device and Use of the Menstrual Cup: Case-control Study
Completed NCT03780985 - Post-placental Intrauterine Device Insertion During Cesarean Section N/A
Completed NCT04178031 - Association Between Clinical, Laboratory, Ultrasongraphy Predictors And Development of Copper IUD Complications N/A